- RevMan 5 is free of charge for preparing Cochrane Reviews or for purely academic use. For commercial use you must purchase a licence to use RevMan 5.All income from commercial licenses is applied to producing Cochrane tools and evidence.
- Please wait, loading.
- I'm currently on the analysis part of my research so when I entered the odds ratio and 95% CI value (i.e. 1.06; 0.82,1.73) from a study onto RevMan, it gave a different.
RevMan 5 for non-Cochrane reviews. Cochrane's RevMan 5 (Review Manager) software is freely available to download for academic and non-commercial use. The RevMan user guide provides useful guidance for all users. If you are not using RevMan 5 to write a Cochrane review, please ensure you run RevMan 5 in non-Cochrane mode for optimal performance.
We've today heard that RevMan 5.2 will be released this year, not RevMan 6 as previously announced. The main changes to this version will affect Diagnostic Test Accuracy (DTA) reviews and so unlikely to affect many of our authors as we currently have no DTA reviews registered. Here's more detail from the message we received today:
For authors of ongoing DTA reviews, upgrading to RevMan 5.2 will be mandatory and will feature some important changes to the tool for assessing study quality. The DTA group will shortly be circulating updated advice to DTA review authors and MEs about these changes. Published DTA reviews will not need to be converted to RevMan 5.2 until they are republished.
For authors of intervention, overview and methodology review types this release will be optional.
The changes being implemented in RevMan 5.2 will be detailed further and circulated prior to its release.
Revman 5.3 Slow
An all entities message will shortly be circulated announcing this change and outlining plans for developing RevMan 6, including an invitation to suggest items for the RevMan wishlist. RevMan 6 is scheduled for release in 2014.